ArticleAnnals of the rheumatic diseases2006
Differential drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.
Article in Annals of the rheumatic diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Randomised controlled trial examining the effect of exercise in people with rheumatoid arthritis taking anti-TNFα therapy medication.BMC musculoskeletal disorders · 2011Trial
- Programmatically activated DNA hydrogel microcapsules for precision therapy in inflammatory bowel disease.Theranostics · 2025Article
- TIPE2 inhibits melanoma progression through MEK/ERK signaling.Scientific reports · 2024Article
- Inference of an Integrative, Executable Network for Rheumatoid Arthritis Combining Data-Driven Machine Learning Approaches and a State-of-the-Art Mechanistic Disease Map.Journal of personalized medicine · 2021Article
- Psoriasis and Gut Microbiome-Current State of Art.International journal of molecular sciences · 2021Review
- Review
- Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion.Scientific reports · 2018Article
- Dose Escalation and Co-therapy Intensification Between Etanercept, Adalimumab, and Infliximab: The CADURA Study.The open rheumatology journal · 2017Article
- TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification.Cellular signalling · 2013Review
- The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients.Arthritis research & therapy · 2013Observational
- Immunogenicity of Anti-TNF-alpha agents in autoimmune diseases.Clinical reviews in allergy & immunology · 2010Review
- [Modern therapy for systemic lupus erythematosus].Zeitschrift fur Rheumatologie · 2007Review
- Biologic therapy for inflammatory bowel disease comes of age.Current gastroenterology reports · 2007Article
- Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.